Miles Carroll
Contact information
Research groups
Miles Carroll
Professor of Emerging Viruses
HOST-PATHOGEN INTERACTIONS OF HIGH CONSEQUENCE EMERGING VIRUSES
Our work centres around high consequence emerging viral infections. Currently, our focus is on Ebola, Lassa fever and SARS-CoV-2. We are interested in host-pathogen interactions, development of anti-virals and recently we have been looking at the IgG response following SARS-CoV-2 infection and/or vaccination in humans and animal models. To further support this work we are using a live virus neutralisation, multiplex immunoassays and novel ACE2 inhibition assay to inform on the ability of serum to neutralise SARS-CoV-2 variants of concern (VOC). We are also interested in the innate response to viral infection, particularly activation and/or evasion of the complement system
Recent publications
The development of biologically contained Sudan virus as an alternative and safe tool for fundamental filovirus research.
Journal article
Verlinden J. et al, (2026), Emerging microbes & infections, 15
A modified vaccinia Ankara (MVA) virus vectored Zika vaccine that generates neutralising antibodies and potent T cell responses in type I interferon deficient mice.
Journal article
Subramaniam KS. et al, (2026), Vaccine, 96
Filovirus reactive antibodies in wildlife hunting communities suggest ongoing zoonotic spillover in forested Guinea
Journal article
Hood G. et al, (2026), Nature Communications, 17
Spike antibody Fc is associated with protection from SARS-CoV-2 challenge in macaques.
Journal article
Brady C. et al, (2026), Vaccine, 93
Cephalosporins are potent SARS-CoV-2 main protease inhibitors
Journal article
Muntean D-G. et al, (2026), European Journal of Medicinal Chemistry, 316, 118995 - 118995